These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31565750)

  • 1. Hemagglutinin Stalk Antibody Responses Following Trivalent Inactivated Influenza Vaccine Immunization of Pregnant Women and Association With Protection From Influenza Virus Illness.
    Dhar N; Kwatra G; Nunes MC; Cutland C; Izu A; Nachbagauer R; Krammer F; Madhi SA
    Clin Infect Dis; 2020 Aug; 71(4):1072-1079. PubMed ID: 31565750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccination of pregnant women and protection of their infants.
    Madhi SA; Cutland CL; Kuwanda L; Weinberg A; Hugo A; Jones S; Adrian PV; van Niekerk N; Treurnicht F; Ortiz JR; Venter M; Violari A; Neuzil KM; Simões EA; Klugman KP; Nunes MC;
    N Engl J Med; 2014 Sep; 371(10):918-31. PubMed ID: 25184864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV.
    Motsoeneng BM; Dhar N; Nunes MC; Krammer F; Madhi SA; Moore PL; Richardson SI
    Front Immunol; 2022; 13():873191. PubMed ID: 35514992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice.
    Bliss CM; Freyn AW; Caniels TG; Leyva-Grado VH; Nachbagauer R; Sun W; Tan GS; Gillespie VL; McMahon M; Krammer F; Hill AVS; Palese P; Coughlan L
    Mol Ther; 2022 May; 30(5):2024-2047. PubMed ID: 34999208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the Protective Potential of H1N1 Influenza Virus Hemagglutinin Head and Stalk Antibodies in Humans.
    Christensen SR; Toulmin SA; Griesman T; Lamerato LE; Petrie JG; Martin ET; Monto AS; Hensley SE
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemagglutinin Stalk-Specific Fc-Mediated Functions Are Associated With Protection Against Influenza Illness After Seasonal Influenza Vaccination.
    Motsoeneng BM; Dhar N; Nunes MC; Krammer F; Madhi SA; Moore PL; Richardson SI
    J Infect Dis; 2024 Dec; 230(6):1329-1336. PubMed ID: 38743692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.
    Park JK; Han A; Czajkowski L; Reed S; Athota R; Bristol T; Rosas LA; Cervantes-Medina A; Taubenberger JK; Memoli MJ
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination of pregnant women protects them over two consecutive influenza seasons in a randomized controlled trial.
    Mutsaerts E; Madhi SA; Cutland CL; Jones S; Hugo A; Trenor S; Treurnicht FK; Klipstein-Grobusch K; Weinberg A; Nunes MC
    Expert Rev Vaccines; 2016 Aug; 15(8):1055-62. PubMed ID: 27212228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
    Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
    PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses to influenza a H1N1 vaccine compared to the circulating strain in influenza vaccine recipients during the 2013/2014 season in North America.
    Barron MA; Frank DN; Claypool D; Ir D; Ning MF; Curtis D; Weinberg A
    J Clin Virol; 2016 Oct; 83():56-60. PubMed ID: 27591557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.
    Krammer F; Hai R; Yondola M; Tan GS; Leyva-Grado VH; Ryder AB; Miller MS; Rose JK; Palese P; García-Sastre A; Albrecht RA
    J Virol; 2014 Mar; 88(6):3432-42. PubMed ID: 24403585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of pre-existing immunity on the induction of functional cross-reactive anti-hemagglutinin stalk antibodies following vaccination with an AS03 adjuvanted pandemic H1N1 vaccine.
    Tete SM; Jul-Larsen Å; Rostami S; Lunde THF; Søland H; Krammer F; Cox RJ
    Vaccine; 2018 Apr; 36(16):2213-2219. PubMed ID: 29548607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.
    Liu WC; Nachbagauer R; Stadlbauer D; Solórzano A; Berlanda-Scorza F; García-Sastre A; Palese P; Krammer F; Albrecht RA
    Front Immunol; 2019; 10():756. PubMed ID: 31105689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anamnestic broadly reactive antibodies induced by H7N9 virus more efficiently bind to seasonal H3N2 strains.
    Chen Y; Hilchey SP; Wang J; Garigen J; Zand MS; Huang J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128014. PubMed ID: 36197079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.
    Islam S; Mohn KG; Krammer F; Sanne M; Bredholt G; Jul-Larsen Å; Tete SM; Zhou F; Brokstad KA; Cox RJ
    Vaccine; 2017 Oct; 35(42):5666-5673. PubMed ID: 28899626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
    Frey SE; Bernstein DI; Brady RC; Keitel WA; El Sahly H; Rouphael NG; Mulligan MJ; Atmar RL; Edupuganti S; Patel SM; Dickey M; Graham I; Anderson EL; Noah DL; Hill H; Wolff M; Belshe RB
    Vaccine; 2015 Jan; 33(1):163-73. PubMed ID: 25444805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
    Houser KV; Yamshchikov GV; Bellamy AR; May J; Enama ME; Sarwar U; Larkin B; Bailer RT; Koup R; Paskel M; Subbarao K; Anderson E; Bernstein DI; Creech B; Keyserling H; Spearman P; Wright PF; Graham BS; Ledgerwood JE;
    PLoS One; 2018; 13(11):e0206837. PubMed ID: 30388160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans.
    Nachbagauer R; Choi A; Izikson R; Cox MM; Palese P; Krammer F
    mBio; 2016 Jan; 7(1):e01996-15. PubMed ID: 26787832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination.
    Manenti A; Tete SM; Mohn KG; Jul-Larsen Å; Gianchecchi E; Montomoli E; Brokstad KA; Cox RJ
    Vaccine; 2017 Jan; 35(1):191-198. PubMed ID: 27789145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.